作者: S. J. Kim , M. Hong , I.-G. Do , S. H. Lee , K. J. Ryu
DOI: 10.3324/HAEMATOL.2014.116087
关键词: Extranodal NK/T-cell lymphoma, nasal type 、 Epstein–Barr virus infection 、 Vascular endothelial growth factor 、 Vascular endothelial growth factor A 、 Nose neoplasm 、 Survivin 、 Biology 、 Chemotherapy 、 Lymphoma 、 Cancer research
摘要: Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive subtype of non-Hodgkin showing frequent resistance to anthracyclines.[1][1] Although intensified, non-anthracycline-based chemotherapy regimens have improved clinical outcomes, the prognosis ENKTL, especially advanced